Skip to content

Drug interactions

Eltrombopag + Talazoparib

Severity: Moderate

Eltrombopag and Talazoparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eltrombopag inhibits BCRP, which may increase exposure to talazoparib, a BCRP substrate. This may worsen myelosuppression, particularly anemia and thrombocytopenia.

What this interaction means in plain words

Eltrombopag and Talazoparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eltrombopag belongs to Miscellaneous; Talazoparib belongs to Oncology.

Evidence level: Low

Why it happens

BCRP inhibition by eltrombopag reduces talazoparib efflux and may raise systemic exposure.

What to do

Monitor complete blood counts closely if the combination is used. Reduce or interrupt the talazoparib dose for significant hematologic toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eltrombopag and Talazoparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eltrombopag with Talazoparib?

MediHelp rates the interaction as moderate. Eltrombopag and Talazoparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eltrombopag inhibits BCRP, which may increase exposure to talazoparib, a BCRP substrate. This may worsen myelosuppression, particularly anemia and thrombocytopenia.

How serious is the interaction between Eltrombopag and Talazoparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts closely if the combination is used. Reduce or interrupt the talazoparib dose for significant hematologic toxicity.

What other medicines interact with Eltrombopag?

MediHelp also lists interactions of Eltrombopag with, for example, Alpelisib, Aluminum hydroxide, Amobarbital. The full list is on the Eltrombopag page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in